RX724
Pill imprint RX724 has been identified as Loratadine and pseudoephedrine extended release 10 mg / 240 mg.
Loratadine/pseudoephedrine is used in the treatment of nasal congestion; hay fever and belongs to the drug class upper respiratory combinations. There is no proven risk in humans during pregnancy.
Loratadine/pseudoephedrine 10 mg / 240 mg is not subject to the Controlled Substances Act.
See also related documents.
Loratadine and pseudoephedrine extended release Images
- Imprint:
-
RX724
- Strength:
- 10 mg / 240 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Rx and/or OTC
- Drug Class:
- Upper respiratory combinations
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Major Pharmaceuticals Inc.
Advertisement
More Loratadine and Pseudoephedrine Extended Release resources
- Loratadine and Pseudoephedrine Extended Release Side Effects
- Loratadine and Pseudoephedrine Extended Release Use in Pregnancy & Breastfeeding
- Loratadine and Pseudoephedrine Extended Release Drug Interactions
- Support Group Q & A
- 13 Reviews for Loratadine and Pseudoephedrine Extended Release - Add your own review/rating
- Alavert Allergy & Sinus 12-Hour Sustained-Release Tablets (Wolters Kluwer)
- Loratadine/Pseudoephedrine 12-Hour Sustained-Release Tablets (Wolters Kluwer)
- Loratadine/Pseudoephedrine 24-Hour Sustained-Release Tablets (Wolters Kluwer)
- loratadine and pseudoephedrine (Cerner Multum)
- Loratadine/Pseudoephedrine Sulfate (Wolters Kluwer)
Search Again
